Hydroxyurea increases the phosphorylation of 3'-fluorothymidine and 3'-azidothymidine in CEM cells.
The triphosphates of the nucleoside analogues 3'-azidothymidine and 3'-fluorothymidine inhibit reverse transcriptase and are of therapeutic interest for the treatment of retrovirus infections. At equimolar concentrations 3'-fluorothymidine was more effectively transformed to the triphosphate by human CEM cells than azidothymidine which mainly accumulates as the monophosphate. Hydroxyurea, a drug that inhibits de novo synthesis of deoxyribonucleotides, considerably increased the ability of cells to phosphorylate both analogues. Addition of as little as 50 microM hydroxyurea decreased the amount of dideoxynucleoside required to attain a given intracellular concentration of its triphosphate by an order of magnitude. Hydroxyurea is known to shift the balance of substrate cycles between natural deoxynucleosides and their 5'-phosphates in the direction of synthesis and thereby to increase the import and intracellular phosphorylation of the nucleoside. The present results demonstrate a similar effect for the two analogues and raise the possibility of using this effect in therapy.
Karlsson
A
A
Department of Biochemistry 1, Medical Nobel Institute, Karolinska Institute, Stockholm, Sweden.
Reichard
P
P
Eckstein
F
F
D000998:Antiviral Agents / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D003854:Deoxyribonucleotides / Q000096:biosynthesis; D015224:Dideoxynucleosides / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D006918:Hydroxyurea / Q000378:metabolism*; D007700:Kinetics; D010766:Phosphorylation; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism*; D015215:Zidovudine / Q000378:metabolism* / Q000494:pharmacology
D000998:Antiviral Agents; D003854:Deoxyribonucleotides; D015224:Dideoxynucleosides; D015215:Zidovudine; C002854:alovudine; D006918:Hydroxyurea